X-CLX-Shades: |
Deliver |
X-CLX-Response: |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= |
Date: |
Thu, 10 Oct 2024 09:26:21 +0200 |
Reply-To: |
|
Approved-By: |
|
Message-ID: |
|
MIME-Version: |
1.0 |
Subject: |
|
Emisor: |
|
Received: |
by LISTSERV.REDIRIS.ES (LISTSERV-TCP/IP release 17.0) with spool id
10816101 for [log in para visualizar]; Thu, 10 Oct 2024
09:28:25 +0200
from mx08-006a4e02.pphosted.com (mx08-006a4e02.pphosted.com
[143.55.148.243]) by listserv.backend.rediris.es (Postfix) with ESMTP
id 59A92192F1A for < [log in para visualizar]>; Thu, 10 Oct
2024 09:26:22 +0200 (CEST)
from pps.filterd (m0316695.ppops.net [127.0.0.1]) by
mx08-006a4e02.pphosted.com (8.18.1.2/8.18.1.2) with ESMTP id
49A6wvqk003480 for < [log in para visualizar]>; Thu, 10 Oct
2024 09:26:22 +0200
from satellite02.sim.rediris.es (satellite02.sim.rediris.es
[130.206.24.61]) by mx08-006a4e02.pphosted.com (PPS) with ESMTPS id
426a4rrfc0-1 (version=TLSv1.2 cipher=ECDHE-RSA-AES256-GCM-SHA384
bits=256 verify=NOT) for < [log in para visualizar]>; Thu, 10
Oct 2024 09:26:21 +0200 (MEST)
from satellite02.sim.rediris.es (localhost.localdomain [127.0.0.1])
by satellite02.sim.rediris.es (Postfix) with ESMTPS id 4037CC00A3 for
< [log in para visualizar]>; Thu, 10 Oct 2024 09:26:21 +0200
(CEST)
from localhost (localhost.localdomain [127.0.0.1]) by
satellite02.sim.rediris.es (Postfix) with ESMTP id 3A5A9C00B8 for
< [log in para visualizar]>; Thu, 10 Oct 2024 09:26:21 +0200
(CEST)
from satellite02.sim.rediris.es ([127.0.0.1]) by localhost
(satellite02.sim.rediris.es [127.0.0.1]) (amavis,
port 10026) with ESMTP id P9CNMTzywOxk for
< [log in para visualizar]>; Thu, 10 Oct 2024 09:26:21 +0200
(CEST)
from web-node01.backend.rediris.es (web-node01.backend.rediris.es
[130.206.25.31]) by satellite02.sim.rediris.es (Postfix) with ESMTP
id 26D90C00A3 for < [log in para visualizar]>; Thu, 10 Oct 2024
09:26:21 +0200 (CEST)
by web-node01.backend.rediris.es (Postfix,
from userid 48) id 1869B85D44; Thu, 10 Oct 2024 09:26:21 +0200 (CEST) |
Content-Type: |
text/plain; charset=UTF-8; |
X-Amavis-Modified: |
Mail body modified (using disclaimer) -
satellite02.sim.rediris.es |
Delivered-To: |
|
X-Proofpoint-ORIG-GUID: |
qd0ESnrrvtzmtdwvUCb4Ky10VCmyvCms |
Sender: |
|
X-Proofpoint-Spam-Details: |
rule=politica_listserv_notspam
policy=politica_listserv score=0 suspectscore=0
impostorscore=0 priorityscore=1000 mlxscore=0
clxscore=1000 lowpriorityscore=0 malwarescore=0
phishscore=0 mlxlogscore=999 adultscore=0
bulkscore=0 spamscore=0 classifier=customer_allow
adjust=0 reason=mlx scancount=1
engine=8.19.0-2409260000 definitions=main-2410100047
domainage_hfrom=1514 |
X-Proofpoint-Virus-Version: |
vendor=baseguard
engine=ICAP:2.0.293,Aquarius:18.0.1039,Hydra:6.0.680,FMLib:17.12.60.29
definitions=2024-09-11_02,2024-09-09_02,2024-09-02_01 |
X-Proofpoint-GUID: |
qd0ESnrrvtzmtdwvUCb4Ky10VCmyvCms |
Parts/Attachments: |
|
|
===
Para darse de ALTA/BAJA del Boletin OFER-TRABEC utilice el siguiente enlace o pongase en contacto con [log in para visualizar]
https://listserv.rediris.es/cgi-bin/wa?SUBED1=OFER-TRABEC&A=1
===
SEGURIDAD: Los enlaces contenidos en este mensaje son seguros y protegidos con reescritura de URL_DEFENSE de Proofpoint
===
---Procedencia:
Institución:The Pere Virgili Institute for Health Research (IISPV)
Contacto correo-e:[log in para visualizar]
---
NAME OF THE JOB
DEGREE IN BIOLOGY FOR WORKING IN MODALITY B PRODUCTE INNOVATION PROJECT “MOTLLES EMMA”
Funded by the Innovation Project. Mode: B: PRODUCT. Cod exp: 2023 PROD 00085. PROJECT: EMMA MOLDS RESOLUTION REU/2813/2023, of July 27, which approves the regulatory bases for the Knowledge Industry grants with the support of the “Departament de Recerca i Universitats de la Generalitat de Catalunya”.
The Pere Virgili Institute for Health Research (IISPV) is an institution that integrates research in the field of biomedicine in the “Camp de Tarragona” and the “Terres de l’Ebre”. The IISPV is the instrument that the university hospitals of both health regions have been endowed with (Joan XXIII University Hospital of Tarragona, Verge de la Cinta Hospital of Tortosa, Sant Joan de Reus University Hospital, Institut Pere Mata University Hospital of Reus) and Rovira and Virgili University, in order to bring together and manage biomedical research and innovation in the territory.
The Oncological Pathology and Bioinformatics (OP&B) team of the IISPV, based at the Hospital de Tortosa Verge de la Cinta, has been working for more than 15 years on the prevention and advanced diagnosis of cancer. Led by Dra. Marylène Lejeune and Dr. Carlos López, the PO&B team is an interdisciplinary group that includes pathologists, oncologists, hematologists, biologists, biotechnologists and computer specialists, with strategic clinical and methodological skills for the development of the group’s research lines.
The consolidated lines of research of the OP&B team focus on the study of the tumor microenvironment through digital image analysis and mathematical modeling. The immune response is one of the components of the tumor microenvironment that has been shown to play an important role in the evolution of cancer patients. Changes in the type and amount of immune cells in the tumor microenvironment have been related to differences in disease functionality. Our team has studied these changes through the development of new computer-assisted image analysis algorithms capable of providing more accurate and reproducible automated quantification of immune biomarkers with immunohistochemical and fluorescence staining.
Number of available positions:1
JOB DESCRIPTION
The chosen person will have to carry out, mainly, these tasks:
The selected candidate will perform the following tasks:
Selection of optimal tissue samples.
Testing of the prototype developed in the laboratory.
Preparation of HE stains, immunohistochemistry.
Validation and quality control of the obtained samples.
Presentation of results to collaborators.
Searching bibliography and writing reports and articles related to the project.
Assistance to the preparation of stands at fairs and congresses.
Other tasks related to the project and molecular biology techniques.
PROFILE OF THE CANDIDATE
Degree in Biology or Life Sciences.
Master’s degree in Biotechnology.
Experience in biological samples management.
Experience in the research field.
Speaking and written English skills (minimun B2 level or similar).
Minimum knowledge of image analysis software.
REQUIREMENTS
Degree or Degree in Biology
IT WILL BE VALUED
Ability for personal relationships.
Motivation, creativity, initiative and proactive attitude.
Ability to learn, flexibility and adaptability.
Commitment to quality, to optimizing resources and to achieving results.
Advanced skills in molecular biology techniques.
Complementary training in immunology.
Knowledge of image analysis software.
Notions in data science management.
Previous experience in similar projects.
Ability to identify and solve problems.
Previous experience in writing reports and scientific articles.
Teamwork, ability to work independently, organization, kindness, dynamism, versatility, rigour, responsibility and confidentiality.
Carry out research under supervision.
Have the ambition to develop knowledge of research methodologies and discipline.
Have demonstrated a good understanding of a field of study.
Have demonstrated the ability to produce data under supervision.
SELECTION PROCEDURE
Selection of CVs: Suitable and unsuitable CVs will be identified according to the requirements. Applicants who do not meet the requirements indicated in the point profile of the person and requirements will not move on to the next phase.
CV assessment Assessment of CVs up to a maximum score of 40 points.
Written letter of motivation: Attach to the CV a letter of motivation with a maximum length of 2500 characters with spaces. With a maximum score of 10 points.
To access the interview phase, it is necessary to have obtained a minimum score of 35 points in the sum of the scores of the assessment of the CV and motivation letter.
Personal interview. With a maximum score of 50 points.
Items 50
Attitude 10
Fit in the workplace 25
Experience, functions developed/skills 10
Teamwork 5
The selected person must have obtained a minimum score of 35 points in the sum of the scores of the assessment of all phases of the selection procedure.
SELECTION COMMITTEE
President/a: Carlos López Pablo. (Group Leader)
Member 1: Esther Sauras Colón. (Researcher)
Member 2: Emma Forcadell Drago. (Postdoctoral Researcher)
SUBSTITUTES:
President/a: Marylène Lejeune. (Principal Investigator)
Member 1: Vocal 1: Ramon Bosch Príncep. (Postdoctoral Researcher)
Member 2: Laia Reverté Calvet. (Postdoctoral Researcher)
CANDIDACIES
The CV must include the DNI/NIE number or personal identity document
Send your CV and Motivation Letter through the IISPV website https://www.iispv.cat/treballa-amb-nosaltres/
For any doubts or questions: [log in para visualizar]
DEADLINE FOR RECEIPT OF CV 23/10/2024
COMMUNICATIONS
The IISPV will inform candidates through the website if they have been admitted or excluded from accessing the interview.
HR EXCELLENCE IN RESEARCH
The IISPV will guarantee the right to equal opportunities and treatment, as well as the real and effective exercise of rights by people with disabilities on equal terms with other citizens, through the promotion of personal autonomy, universal accessibility, access to employment, inclusion in the community and independent living and the eradication of any form of discrimination. in accordance with Articles 9.2, 10, 14 and 49 of the Spanish Constitution and the International Convention on the Rights of Persons with Disabilities and the international treaties and agreements ratified by Spain.
In the event of a tie, priority will be given to hiring the person with a disability.
In the event of a tie between people of different genders, the person of the least represented gender in the work group/department/service in which they join will be hired.
The IISPV has the European accreditation The Human Resources Strategy for Researchers (HRS4R), complies with the general principles of the European Charter for Researchers and the Code of Conduct for the recruitment of researchers.
----------------
Información complementaria de la oferta:
WORKING CONDITIONS
Type of working day: full
Physical place of work: Hospital de Tortosa Verge de la Cinta
Contract: Indefinite linked to the Project MODALITY B PRODUCTE INNOVATION PROJECT “MOTLLES EMMA”.
Remuneration: 25.000€ - 27.000€ gross per year
Approximate incorporation: November 7th, 2024
|